External pancreatic duct stents after pancreatic surgery
Part of Digestive system clinical trials.
This study tests whether placing an external pancreatic duct stent after pancreaticoduodenectomy can lower the risk of pancreatic leak (pancreatic fistula). If you had this surgery with a specific connection technique, you may be able to help find a safer way to prevent complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You already had a pancreatoduodenectomy with the surgeon connecting the pancreas to the small intestine using a “pancreaticojejunal mucosa” join
- You do not have major heart, lung, or kidney illnesses that would make surgery unsafe
- You have not had chemotherapy, radiation, or prior upper-abdomen surgery, and you don’t have other cancers
- Your pancreatic leak risk score (ua-FRS) is above 5%
- You do not have multiple tumors or spread to distant organs
- You are between 18 and 75 years old
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether washing the inside lining of the abdomen during surgery can reduce the risk of a pancreas leak (called a pancreatic fistula) and related complications after a Whipple-type operation. If you are having this surgery for certain tumors, the study may help improve safety and recovery.
This trial tests if placing a small tube (stent) in the pancreas during Whipple surgery helps prevent leaks. It is for patients whose pancreas is found to be soft during surgery.
This trial tests if a short course of radiation before surgery can lower the risk of a pancreatic leak (a common complication). It is for people who are overweight, older than 45, and have a small pancreatic duct.
This trial looks at factors that can predict a serious complication called a pancreatic fistula (a leak from the pancreas) after a Whipple procedure. The goal is to help doctors better understand and manage this risk.
This study tests if octreotide microspheres (a slow-release drug) can prevent pancreatic fistula—a common complication after surgery to remove the tail of the pancreas. The goal is to help patients heal with fewer complications.
This study looks at people having planned Whipple surgery (a type of pancreas surgery) to understand why some develop a leak called a pancreatic fistula. Researchers will study your blood and immune system to find ways to predict and prevent this complication.
Hear when a new Pancreatic Fistula trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.